Interactions between drugs and occupied receptors

Pharmacology and Therapeutics

Volumn 113, Issue 1, 2007, Pages 197-209

  Tallarida, Ronald J ^a  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Additivity; Isobole; Knockout animals; Muscarinic receptors; Receptor interaction; Schild plot; Synergism

Indexed keywords

CARBACHOL; DELTA OPIATE RECEPTOR AGONIST; DELTORPHIN [2 DEXTRO ALANINE 4 GLUTAMINE]; DRUG RECEPTOR; ENKEPHALIN[2,5 DEXTRO PENICILLAMINE]; GLUCOSAMINE; IBUPROFEN; MORPHINE;

DRUG ANTAGONISM; DRUG EFFICACY; DRUG MECHANISM; DRUG POTENCY; DRUG RECEPTOR BINDING; MATHEMATICAL ANALYSIS; NONHUMAN; PRIORITY JOURNAL; REVIEW;

ANIMALS; BINDING, COMPETITIVE; COMPUTER SIMULATION; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ANTAGONISM; DRUG INTERACTIONS; DRUG SYNERGISM; HUMANS; KINETICS; MODELS, STATISTICAL; PHARMACEUTICAL PREPARATIONS; RECEPTORS, DRUG;

EID: 33845716253     PISSN: 01637258     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pharmthera.2006.08.002     Document Type: Review

References (37)

1. Arunlakshana O., and Schild H.O. Some quantitative use of drug antagonists. Br J Pharmacol 14 (1959) 48-57
2. Berenbaum M.C. What is synergy?. Pharmacol Rev 41 (1989) 93-141
3. Bolan E.A., Tallarida R.J., and Pasternak G.W. Synergy between mu receptor subtypes: evidence for functional interaction among mu receptor subtypes. J Pharmacol Exp Ther 303 (2002) 557-562
4. Choppin A., and Eglen R.M. Pharmacological characterization of muscarinic receptors in mouse isolated urinary bladder smooth muscle. Br J Pharmacol 133 (2001) 1035-1040
5. DiFazio C.A., Brown R.E., Ball C.G., Heckel C.G., and Kennedy S.S. Additive effects of anesthetics and theories of anesthesia. Anesthesiology 36 (1972) 57-63
6. Eglen R.M., and Whiting R.L. Estimation of apparent agonist affinity constants using desensitization of the ileal muscarinic receptor. J Pharmacol Exp Ther 240 (1987) 404-409
7. Field M.K., Gonzalez M.I., Tallarida R.J., and Singh L. Gabapentin and the NK1 antagonist CI-1021 act synergistically in two rat models of neuropathic pain. J Pharmacol Exp Ther 303 (2002) 730-735
8. Furchgott R.F. The use of beta-haloalkylamines in the differentiation of receptors and the determination of dissociation constants of receptor agonist complexes. Adv Drug Res 3 (1966) 21-55
9. Furchgott R.F., and Bursztyn P. Comparison of dissociation constants and of relative efficacies of selected agonists acting on parasympathomimetic receptors. Ann N Y Acad Sci 144 (1967) 882-893
10. Gaddum J. The quantitative effects of antagonistic drugs. J Physiol (London) 89 (1937) 7P-9P
11. Gershwin M.E., and Smith N.T. Interaction between drugs using three dimensional isobolographic interpretation. Arch Int Pharmacodyn Ther 201 (1973) 154-161
12. Gessner P.K., and Cabana B.E. A study of the hypnotic effects and the toxic effects chloral hydrate and ethanol. J Pharmacol Exp Ther 174 (1970) 247-259
13. Grabovsky Y., and Tallarida R.J. Isobolographic analysis for combinations of a full and partial agonist: curved isoboles. J Pharmacol Exp Ther 310 (2004) 981-986
14. Horan P., Tallarida R.J., Haaseth R.C., Matsunaga T.O., Hruby V.J., and Porreca F. Antinociceptive interactions of opioid delta receptor agonists with morphine in mice: supra- and subadditivity. Life Sci 50 (1992) 1535-1541
15. Kimmel H.L., Tallarida R.J., and Holtzman S.G. Synergism between buprenorphine and cocaine on the rotational behavior of the nigrally-lesioned rat. Psychopharmacology 133 (1997) 372-378
16. Loewe S. Die Mischiarnei. Klin Wochenschr 6 (1927) 1077-1085
17. Loewe S. Die quantitativen Probleme der Pharmakologie. Ergeb Physiol 27 (1928) 47-187
18. Loewe S. The problem of synergism and antagonism of combined drugs. Arzneimittelforschung 3 (1953) 285-290
19. Loewe S., and Muischnek H. Uber Kombinationswirkungen.I.Mitteilung: Hilfsmittel der Fragestellung. Arch Exp Path Pharmakol 114 (1926) 313-326
20. Miranda H.F., Sierraita F., and Pinardi G. Neostigmine interactions with nonsteroidal anti-inflammatory drugs. Br J Pharmacol 135 (2002) 1591-1597
21. Masusda Y., Utsui Y., Shiraishi Y., Karasawa T., Yoshida K., and Shimzu M. Evidence for a synergistic interaction between phenytoin and phenobarbital in experimental animals. J Pharmacol Exp Ther 217 (1981) 805-811
22. Pircio A.W., Buyniski J.P., and Ruebel L.E. Pharmacological effects of a combination of butorphanol and acetaminophen. Arch Int Pharmacodyn Ther 235 (1978) 116-123
23. Raffa R.B., Friderichs E., Reimann W., Shank R.P., Codd E.E., Vaught J.L., et al. Complementary and synergistic antinociceptive interaction between the enantiomers of tramadol. J Pharmacol Exp Ther 267 1 (1993) 331-340
24. Raffa R.B., Stone Jr. D.J., and Tallarida R.J. Discovery of 'self-synergistic' spinal/supraspinal antinoci-ception produced by acetaminophen (paracetamol). J Pharmacol Exp Ther 295 (2000) 291-294
25. Rawls S.M., Cowan A., Tallarida R.J., Geller E.B., and Adler M.W. N-methyl-d-aspartate antagonists and WIN 55212-2 [4,5-dihydro-2-methyl-4(4-morpholinylmethyl)-1-(1-naphthalenyl-carbonyl)-6H-pyrrolo[3,2,1-i,j]quinolin-6-one], a cannabinoid agonist, interact to produce synergistic hypothermia. J Pharmacol Exp Ther 303 1 (2002) 395-402
26. 2, a new scale for the measurement of drug antagonism. Br J Pharmacol 2 (1947) 189-206
27. Smith N.T., and Corbascio A.N. Interaction between pentobarbital and decreased calcium ion in guinea pig atria. Anesth Analg Curr Res 45 (1966) 576-581
28. Tallarida R.J. Statistical analysis of drug combinations for synergism. Pain 49 (1992) 93-97
29. Tallarida R.J. Drug Synergism and Dose-Effect Data Analysis (monograph) (2000), CRC/Chapman-Hall, Boca Raton
30. Tallarida R.J. Drug synergism: its detection and applications. perspectives in pharmacology (invited review). J Pharmacol Exp Ther 298 (2001) 865-872
31. Tallarida R.J. The interaction index: a measure of drug synergism. Pain 98 (2002) 163-168
32. Tallarida R.J. Commentary on neostigmine interactions with non steroidal anti-inflammatory drugs by Miranda et al. Br J Pharmacol 135 (2002) 1589-1590
33. Tallarida, R. J. (2006). An Overview of drug combination analysis with isobolograms. J Pharmacol Exp Ther. 319, 1-7.
34. 2 and receptor differentiation: a statistical analysis of competitive antagonism. Mini-rev Life Sci 25 (1979) 637-654
35. Tallarida R.J., Cowan A., and Raffa R.B. Antinociceptive synergy, additivity, and subadditivity with combinations of oral glucosamine plus nonopioid analgesics in mice. J Pharmacol Exp Ther 307 (2003) 699-704
36. Wessinger W.D. Approaches to the study of drug interactions in behavioral pharmacology. Neurosci Behav Rev 10 (1986) 103-113
37. Yeung J.C., and Rudy T.A. Multiplicative interaction between narcotic agonisms expressed at spinal and supra-spinal sites of antinociceptive actions as revealed by concurrent intrathecal and intracerebroventricular injections of morphine. J Pharmacol Exp Ther 215 (1980) 633-642